Assembly Biosciences Inc (ASMB)
14.72
-0.20
(-1.34%)
USD |
NASDAQ |
Dec 24, 16:00
Assembly Biosciences Cash from Financing (Quarterly): 0.00 for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Gilead Sciences Inc | -1.379B |
| ADMA Biologics Inc | -25.47M |
| Protagonist Therapeutics Inc | 12.05M |
| Precision BioSciences Inc | 3.733M |
| Entrada Therapeutics Inc | -0.011M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -15.24M |
| Cash from Investing (Quarterly) | 24.49M |
| Free Cash Flow | 22.84M |
| Free Cash Flow Per Share (Quarterly) | -2.400 |
| Free Cash Flow to Equity (Quarterly) | -15.24M |
| Free Cash Flow to Firm (Quarterly) | -15.24M |
| Free Cash Flow Yield | 27.22% |